Various mechanisms, such as AChE inhibition, modification of monoamine levels, anti-amyloid aggregation, and antioxidant activities, are the strategies that have been employed for the amelioration of AD symptoms [99, 100]. This evidence concerns the gene ACHE and Alzheimer disease.